The Prevalence Rate of Tuberculin Skin Test Positive by Contacts Group to Predict the Development of Active Tuberculosis After School Outbreaks

被引:7
|
作者
Kim, Hee Jin [1 ]
Chun, Byung Chul [2 ]
Kwon, Amy M. [3 ]
Lee, Gyeong-Ho [1 ]
Ryu, Sungweon [1 ]
Oh, Soo Yeon [1 ]
Lee, Jin Beom [1 ]
Yoo, Se Hwa [4 ]
Kim, Eui Sook [5 ]
Kim, Je Hyeong [6 ]
Shin, Chol [6 ]
Lee, Seung Heon [6 ]
机构
[1] Korean Inst TB, Cheongwon, South Korea
[2] Korea Univ, Coll Med, Dept Prevent Med, Seoul, South Korea
[3] Seoul Natl Univ, Dept Stat, SRC, Seoul, South Korea
[4] Hlth Insurance Review & Assessment Serv, Seoul, South Korea
[5] Publ Hlthcare Ctr, Ansan, South Korea
[6] Korea Univ, Coll Med, Ansan Hosp, Dept Internal Med,Div Pulmonary Sleep & Critical, 123 Jeokgeum Ro, Ansan 15355, South Korea
关键词
Adolescent; Disease Outbreaks; Tuberculin Test; Latent Tuberculosis; Tuberculosis;
D O I
10.4046/trd.2015.78.4.349
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: The tuberculin skin test (TST) is the standard tool to diagnose latent tuberculosis infection (LTBI) in mass screening. The aim of this study is to find an optimal cut-off point of the TST+ rate within tuberculosis (TB) contacts to predict the active TB development among adolescents in school TB outbreaks. Methods: The Korean National Health Insurance Review and Assessment database was used to identify active TB development in relation to the initial TST (cut-off, 10 mm). The 7,475 contacts in 89 schools were divided into two groups: Incident TB group (43 schools) and no incident TB group (46 schools). LTBI treatment was initiated in 607 of the 1,761 TST+ contacts. The association with active TB progression was examined at different cut-off points of the TST+ rate. Results: The mean duration of follow-up was 3.9 +/- 0.9 years. Thirty-three contacts developed active TB during the 4,504 person-years among the TST+ contacts without LTBI treatment (n=1,154). The average TST+ rate for the incident TB group (n=43) and no incident TB group (n=46) were 31.0% and 15.5%, respectively. The TST+ rate per group was related with TB progression (odds ratio [OR], 1.025; 95% confidence interval [CI], 1.001-1.050; p=0.037). Based on the TST+ rate per group, active TB was best predicted at TST+ >= 16% ( OR, 3.11; 95% CI, 1.29-7.51; area under curve, 0.64). Conclusion: Sixteen percent of the TST+ rate per group within the same grade students can be suggested as an optimal cut-off to predict active TB development in middle and high schools TB outbreaks.
引用
收藏
页码:349 / 355
页数:7
相关论文
共 11 条
  • [1] T-Spot. TB outperforms tuberculin skin test in predicting development of active tuberculosis among household contacts
    Leung, Chi Chiu
    Yam, Wing Cheong
    Ho, Pak Leung
    Yew, Wing Wai
    Chan, Chi Kuen
    Law, Wing Sze
    Lee, Shuk Nor
    Chang, Kwok Chiu
    Tai, Lai Bun
    Tam, Cheuk Ming
    RESPIROLOGY, 2015, 20 (03) : 496 - 503
  • [2] Clinical and demographic characteristics of the tuberculin skin test positive patients without active tuberculosis contact
    Gedik, Ahmet Hakan
    Cakir, Erkan
    Donmez, Tugrul
    Ari, Engin
    Koksalan, Kaya
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [3] Tuberculin skin test and interferon-γ release assay show better correlation after the tuberculin 'window period' in tuberculosis contacts
    Anibarro, Luis
    Trigo, Matilde
    Villaverde, Carlos
    Pena, Alberto
    Gonzalez-Fernandez, Africa
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2011, 43 (6-7) : 424 - 429
  • [4] The predictive values of the tuberculin skin test and interferon-γ release assays for active tuberculosis development
    Hu, Zhidong
    Lu, Shui-Hua
    Lowrie, Douglas B.
    Fan, Xiao-Yong
    LANCET INFECTIOUS DISEASES, 2019, 19 (01) : 19 - 20
  • [5] Agreement between QuantiFERON®-TB Gold In-Tube and the tuberculin skin test and predictors of positive test results in Warao Amerindian pediatric tuberculosis contacts
    Lilly M Verhagen
    Mailis Maes
    Julian A Villalba
    Adriana d’Alessandro
    Lazaro Perez Rodriguez
    Mercedes F España
    Peter WM Hermans
    Jacobus H de Waard
    BMC Infectious Diseases, 14
  • [6] Agreement between QuantiFERON®-TB Gold In-Tube and the tuberculin skin test and predictors of positive test results in Warao Amerindian pediatric tuberculosis contacts
    Verhagen, Lilly M.
    Maes, Mailis
    Villalba, Julian A.
    d'Alessandro, Adriana
    Perez Rodriguez, Lazaro
    Espana, Mercedes F.
    Hermans, Peter W. M.
    de Waard, Jacobus H.
    BMC INFECTIOUS DISEASES, 2014, 14
  • [7] School based screening for tuberculosis infection in Norway: comparison of positive tuberculin skin test with interferon-gamma release assay
    Brita Askeland Winje
    Fredrik Oftung
    Gro Ellen Korsvold
    Turid Mannsåker
    Ingvild Nesthus Ly
    Ingunn Harstad
    Anne Margarita Dyrhol-Riise
    Einar Heldal
    BMC Infectious Diseases, 8
  • [8] Rate of tuberculosis infection in children and adolescents with household contact with adults with active pulmonary tuberculosis as assessed by tuberculin skin test and interferon-gamma release assays
    Ferrarini, M. A. G.
    Spina, F. G.
    Weckx, L. Y.
    Lederman, H. M.
    De Moraes-Pinto, M. I.
    EPIDEMIOLOGY AND INFECTION, 2016, 144 (04) : 712 - 723
  • [9] Detection of latent tuberculosis by the tuberculin skin test and a whole-blood interferon-γ release assay, and the development of active tuberculosis in HIV-seropositive persons
    Santin, Miguel
    Casas, Susana
    Saumoy, Maria
    Andreu, Ana
    Moure, Raquel
    Alcaide, Fernando
    Ferrer, Elena
    Podzamczer, Daniel
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2011, 69 (01) : 59 - 65
  • [10] Post-exposure rate of tuberculosis infection among health care workers measured with tuberculin skin test conversion after unprotected exposure to patients with pulmonary tuberculosis: 6-year experience in an Italian teaching hospital
    Muzzi, Alba
    Seminari, Elena
    Feletti, Tiziana
    Scudeller, Luigia
    Marone, Piero
    Tinelli, Carmine
    Minoli, Lorenzo
    Marena, Carlo
    Mangiarotti, Patrizia
    Strosselli, Maurizio
    BMC INFECTIOUS DISEASES, 2014, 14